DTIL Stock — Precision BioSciences Inc

Precision BioSciences Inc (DTIL)

Updated October 16, 2026.

DTIL is a Stock. Total return is -98.9% over the past 7.6 years, 302.3 points behind SPY at 203.4%.

Precision BioSciences is a clinical-stage gene editing company developing in vivo therapies that use its ARCUS platform to insert, remove, or repair DNA sequences to treat conditions including chronic hepatitis B, Duchenne muscular dystrophy, mitochondrial diseases, and metabolic disorders. The company does not currently have an established dividend distribution program. This security appeals primarily to investors seeking exposure to early-stage biotechnology innovation rather than those focused on current income.

DTIL performance versus SPY

Price and return data through 2026-10-16.

Total return is -98.9% over the past 7.6 years, 302.3 points behind SPY at 203.4%. Over the past year its total return — price change plus distributions reinvested — is -13.1%. Its deepest 1-year drawdown was 58.5%.

DTIL key facts

Asset type

Stock

Asset class

Equity

Inception date

03/28/2019

Distribution frequency

None

Last close

$5.77 (as of 2026-10-16)

Market cap

$159,260,967

Average volume

300247.0

Beta

1.275

Payout ratio

0.0%

Forward P/E

11.7786

EPS

$-1.37

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

DTIL risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 58.5%.

Who may consider DTIL — and who may not

It is a weaker fit for investors who need monthly cash flow (DTIL does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on DTIL

• All tickers starting with D

Tagged: Healthcare.

Frequently asked questions